Commerce Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Hold |
31,340
| – | – | ﹤0.01% | 1054 |
|
|
2025
Q1 | $235K | Buy |
31,340
+290
| +0.9% | +$2.18K | ﹤0.01% | 1090 |
|
|
2024
Q4 | $233K | Sell |
31,050
-225
| -0.7% | -$1.69K | ﹤0.01% | 1104 |
|
|
2024
Q3 | $238K | Sell |
31,275
-1,035
| -3% | -$7.87K | ﹤0.01% | 1127 |
|
|
2024
Q2 | $200K | Hold |
32,310
| – | – | ﹤0.01% | 1154 |
|
|
2024
Q1 | $164K | Buy |
32,310
+13,645
| +73% | +$69.3K | ﹤0.01% | 1156 |
|
|
2023
Q4 | $112K | Sell |
18,665
-895
| -5% | -$5.36K | ﹤0.01% | 1157 |
|
|
2023
Q3 | $138K | Sell |
19,560
-555
| -3% | -$3.93K | ﹤0.01% | 1107 |
|
|
2023
Q2 | $142K | Sell |
20,115
-250
| -1% | -$1.76K | ﹤0.01% | 1115 |
|
|
2023
Q1 | $170K | Buy |
20,365
+5,760
| +39% | +$48K | ﹤0.01% | 1117 |
|
|
2022
Q4 | $168K | Buy |
14,605
+4,235
| +41% | +$48.6K | ﹤0.01% | 1087 |
|
|
2022
Q3 | $130K | Buy |
+10,370
| New | +$130K | ﹤0.01% | 1106 |
|
|
2022
Q2 | – | Sell |
-20,000
| Closed | -$325K | – | 1148 |
|
|
2022
Q1 | $325K | Hold |
20,000
| – | – | ﹤0.01% | 971 |
|
|
2021
Q4 | $277K | Buy |
20,000
+5,000
| +33% | +$69.3K | ﹤0.01% | 1037 |
|
|
2021
Q3 | $216K | Buy |
+15,000
| New | +$216K | ﹤0.01% | 1102 |
|